In trinitrobenzene sulfonic acid (TNBS)-induced colitis, treatment with obestatin (a ghrelin gene-encoded peptide) reduced severity of colitis and was associated with increased colonic mucosal blood flow (Konarska et al., 2018). The gene discussed is GHRL; the disease is colitis.